CareLit Fachartikel
Treatment of Multisystem Langerhans Cell Histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 Studies
M. Minkov, N. Grois, A. Heitger, U. Pötschger, T. Westermeier, H. Gadner · Klinische Pädiatrie · 2000 · Heft 04 · S. 139-144
Dokument
1099310
CareLit-ID
Jahr
2000
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Summary. BACKGROUND: The prognosis of children with multisystem Langerhans cell histiocytosis (LCH) has improved with the application of chemotherapy. However, treatment strategies used varied from conservative approach with treatment only during disease exacerbation to intensive chemotherapy starting immediately after diagnosis. No single drug or regimen has been proven to be superior to the others. Thus, optimal treatment of multisystem LCH remains still an unsolved problem. PATIENTS: Three hundred and twenty-four patients enrolled in the DAL-HX 83 and DAL-HX 90 studies were retrospectively re-evaluated by usi…
Schlagworte
Langerhans cell histiocytosis
therapy
treatment
prognosis
survival
Langerhanszell-Histiozytose
Therapie
Behandlung
Prognose
Überleben
Diagnosis
After
Observation
Mercaptopurine
Blood
Klinische Pädiatrie
